WESTBROOK, Maine, May 3, 2017 /PRNewswire/ -- IDEXX
Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary
diagnostics, veterinary practice software and water microbiology
testing, today announced that the repurchase by the Company of up
to an additional 3.0 million shares of its common stock under its
ongoing share repurchase program has been authorized. Repurchases
may be made in the open market (including through Rule 10b5-1
plans) or in negotiated transactions. These shares are in addition
to the 3,297,887 shares remaining under the Company's share
repurchase program as of April 28,
2017, pursuant to previous Board authorizations. The timing
and amount of any repurchases will be at the discretion of the
Company's management.
About IDEXX Laboratories, Inc.
IDEXX Laboratories,
Inc. is a member of the S&P 500® Index and is a
leader in pet healthcare innovation, serving practicing
veterinarians around the world with a broad range of diagnostic and
information technology-based products and services. IDEXX products
enhance the ability of veterinarians to provide advanced medical
care, improve staff efficiency and build more economically
successful practices. IDEXX is also a worldwide leader in providing
diagnostic tests and information for livestock and poultry and
tests for the quality and safety of water and milk. Headquartered
in Maine, IDEXX Laboratories
employs more than 7,000 people and offers products to customers in
over 175 countries. For more information about IDEXX, visit:
www.idexx.com.
Contact:
Investor Relations:
Kerry
Bennett
207-556-8155
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/idexx-laboratories-announces-increase-in-share-repurchase-program-300450299.html
SOURCE IDEXX Laboratories, Inc.